Objective Stillbirths are among the most common adverse pregnancy outcomes, with 98% occurring in low-income countries. More than one-third occur in sub-Saharan Africa (SSA). However, the medical conditions causing stillbirths and interventions to reduce stillbirths from these conditions are not well documented. We estimated the reductions in stillbirths possible with combinations of interventions.
Objective Stillbirths are among the most common adverse pregnancy outcomes, with 98% occurring in low-income countries. More than one-third occur in sub-Saharan Africa (SSA). However, the medical conditions causing stillbirths and interventions to reduce stillbirths from these conditions are not well documented. We estimated the reductions in stillbirths possible with combinations of interventions. Design We developed a computerised model to estimate the impact of various interventions on stillbirths caused by the most common conditions. The model considered the location of obstetric care (home, clinic or hospital) and each intervention's efficacy, penetration and utilisation. Maternal transfers were also considered.
Setting and population Pregnancies in SSA in 2012.
Methods For each condition, we created a series of scenarios involving different combinations of interventions and modelled their impact on stillbirth rates.
Main outcome measures Stillbirths associated with various maternal and fetal conditions and the percentage reduction with various interventions.
Results Eight to ten maternal and fetal conditions were responsible for most stillbirths, but none for more than 15%. The most common conditions causing stillbirths in SSA include obstructed labour and uterine rupture, fetal distress and umbilical cord complications, fetal growth restriction, pre-eclampsia/ eclampsia, and placental abruption/placenta praevia. Syphilis and malaria contribute smaller numbers. Reducing stillbirths requires appropriate diagnosis and management of each condition, usually including hospital care for monitoring and delivery, often by caesarean section. Maternal syphilis and malaria were the only conditions for which outpatient management alone reduced stillbirth.
Introduction
Stillbirths are among the most common adverse perinatal outcomes worldwide: 98% occur in low-income countries (LIC), mostly in sub-Saharan Africa (SSA) and south Asia.
1,2 Using a 28-week gestational age cut-off, 2.64 million stillbirths occurred worldwide in 2012 with 935 000 in SSA and 1.1 million in south Asia. [1] [2] [3] [4] In addition, an unknown number of stillbirths occur between 20 and 28 weeks of gestation. In the USA and other high-income countries (HIC), about half of all stillbirths greater than 20 weeks occur before 28 weeks of gestation. 5 If this relationship holds true globally, five to six million stillbirths occur annually.
Determining aetiologies in LIC settings is fraught with difficulty. First, no commonly used classification system defines cause of stillbirth. 6 Causes considered numerically important in one system are not mentioned in others. 6 As important, an accurate medical cause of stillbirth generally requires an autopsy, a placental examination including histology, and tests for infections. 7 These capabilities are absent in most LIC settings. Hence, at best we have only broad estimates of the prevalence of the clinical conditions causal for stillbirth in LIC.
The impact of various interventions on stillbirth reduction in LIC have been projected. In the 2011 Lancet stillbirth series, Bhutta et al. 8 estimated that in LIC, comprehensive emergency obstetric services at delivery would accomplish the largest reduction in stillbirths worldwide (nearly 700 000). However, these estimates were not associated with specific obstetric conditions. The next largest impact resulted from screening and treatment of syphilis (136 000) followed by screening and treatment of fetal growth restriction (FGR; 107 000). 8 Appropriate management of hypertensive diseases and post-date pregnancies were each estimated to reduce stillbirths by 50 000, with smaller reductions achieved by appropriate management of malaria, diabetes and folic acid use. Altogether, these interventions at high coverage were estimated to reduce stillbirths by about 45%.
As most interventions address specific medical conditions, the number of fetuses dying from specific conditions must be approximated. Then, the effectiveness of interventions to prevent, diagnose or treat the conditions that cause stillbirth must be estimated, as well as the presumed coverage of the intervention for women delivered at home, in clinics, or in hospitals. Because of these complexities, the impact of various interventions on stillbirth prevalence is not well-established. To address this gap, we developed a model of interventions for stillbirth in SSA, focusing on the conditions that result in stillbirth and the interventions to prevent, diagnose or treat those conditions in the home, clinic and hospital. 9 
Methods
We first conducted a systematic review of the English literature in PubMed, Medline, the Cochrane Library and the World Health Organization database between 1980 and 2015. Additional databases, including the Demographic and Household Surveys and United Nations estimated stillbirth rates, birth rates and utilisation of various interventions. We used search terms 'stillbirth', 'perinatal mortality', 'fetal death', together with 'developing countries', 'low-income countries' and 'Africa'. To estimate an intervention's efficacy, we used the highest quality sources as primary, and when unavailable, data from other sources using the GRADE system were used. 10 Finally, the results were reviewed by experts on stillbirth in LIC and incorporated into the model. MANDATE, is a mathematical model that uses the concepts of penetration (availability), utilisation and efficacy and applies them to obstetric and neonatal medical care in the home, clinic and hospital to approximate the potential lives saved by the intervention when used in a specific geographic area or in a specific population. 9 We divided the interventions into prevention, diagnosis, transport and treatment categories. The final model included eight separate conditions that cause stillbirth, each condition's prevalence and case fatality rate (CFR), and each intervention's efficacy, penetration and utilisation, and the setting of home, clinic or hospital. Efficacy is defined as the benefit from the intervention under ideal conditions; penetration as the availability of the intervention in a specific setting; and utilisation as the correct use of the intervention, when available. The efficacy, penetration and utilisation of each intervention within each setting are presented in the Supplementary material (Tables S1-S3) ; additional details regarding the methodology are given at the MANDATE website.
11 These analyses were performed for SSA for 2012. Based on United Nations data, approximately 33 000 000 births occurred in SSA in 2012. 12 Approximately 50% of all deliveries in SSA occurred at home, 35% in a health clinic and 15% in a hospital. 13 Conditions causing stillbirths that were modelled were divided into maternal medical and fetal conditions and are noted below with their estimated prevalence, CFR and the proportions of stillbirths associated with the condition. The most common maternal conditions causing stillbirth are obstructed labour (4% prevalence, 14% CFR, 15% of stillbirths associated), and uterine rupture (0.12, 95, 3), antepartum haemorrhage including placental abruption (1, 33, 10%), and placenta praevia (0.3, 11, 1%), pre-eclampsia and eclampsia; 5, 8, 14%), and infections including syphilis (6, 6, 10%) and malaria (30, 1, 4%) . With the exception of the infections, each maternal condition generally causes fetal death by asphyxia. 14, 15 For these conditions, we modelled the diagnosis, prevention or treatment of the maternal conditions, not the fetal asphyxia, which mostly cannot be treated effectively in utero. 16 Prevention and or treatment of the maternal condition or delivery by caesarean section (CS) or forceps/vacuum extraction can decrease fetal death from asphyxia. 17, 18 The fetal conditions associated with or causal for stillbirth included in the model with their estimated prevalence, CFR and the proportion of stillbirths associated with the condition are cord accidents (1, 12, 4%), fetal distress (2, 18, 12%), breech and other abnormal presentations (2, 1, 1%), and multiple gestation (1, 2, 1%). Fetal growth restriction (9, 3, 10%) , is associated with stillbirth, but whether FGR causes or simply predicts a future stillbirth is unknown. 19 Nevertheless, for this analysis, we considered FGR as causal because early delivery of growth-restricted fetuses will prevent some stillbirths. Because the management was similar, we combined the following conditions: obstructed labour and uterine rupture, placenta abruption and placenta praevia, pre-eclampsia and eclampsia, and multiple pregnancies and abnormal presentations.
Not modelled in these analyses are stillbirths associated with congenital anomalies and diabetes because their contributions to stillbirth in LIC are relatively small and the effects of potential interventions are less clear than for most other conditions. 20 Stillbirths caused by infections other than malaria and syphilis are also excluded from this analysis because the organisms causing stillbirth are varied, with nearly 100 described to date. 21 In addition, the proportion of stillbirths caused by these infections is unknown, and the associated interventions are also varied. 20 Deaths associated with post-dates are included with fetal distress.
We emphasise that data to support the estimates of intervention efficacy, penetration and utilisation as well as the condition prevalence and CFRs in SSA were often sparse and varied widely. To assess the model's validity, we continuously evaluated the scenarios used to diagnose and treat each condition to confirm that the estimated stillbirth rates were reasonable compared with currently available data. For example, when we created a model for all the interventions appropriate for a given condition, using the current estimations for prevalence, case fatality, and efficacy, penetration and utilisation in the home, clinic and hospital, we evaluated whether the mortality rates approximated published estimates. If the model estimates did not approximate those estimates, we rechecked the model and often made small modifications in the various parameters (within the reported ranges) so that the mortality rates estimated from the model and the published mortality estimates were similar. In addition, for each condition, using the model, we estimated the stillbirth rates if no interventions were available and evaluated whether those results approximated the estimated mortality rates in SSA from specific conditions before the introduction of any interventions. Finally, we set the parameters in the model to those present in high-income countries to confirm that at high efficacy, penetration and utilisation the stillbirth rates would approach the levels in HIC. However, because of the large variations in the available data, we acknowledge that other estimates of many of the individual parameters in the model could be justified.
For these analyses, MANDATE used the international definition of stillbirth as a fetal death occurring at ≥28 weeks of gestation. 9 The interventions are generally presented as preventions first, diagnostic tests second, transfers third, individual treatments fourth, and then combinations of these interventions. For each condition, the model was populated with the estimated prevalence, the case fatality rate, and evidence-based interventions to prevent stillbirths derived from literature review and expert opinion. In general, these scenarios assume 95% penetration and utilisation for each intervention. For each condition, several hypothetical analyses were performed. These included a baseline scenario, i.e. the stillbirths that would have occurred from each condition without any interventions. A second scenario estimated the stillbirth rates with current care. The remaining scenarios describe the stillbirths estimated to occur with various interventions, alone or in combination. Results are generally rounded to the nearest 1000 stillbirths.
Results
We first estimated the number of stillbirths associated with various obstetric and neonatal conditions in SSA for the year 2012. The largest contributors to stillbirth include the combination of obstructed labour and uterine rupture (170 000), fetal distress (not associated with one of the main conditions) and cord accidents (151 000), preeclampsia/eclampsia (132 000), antepartum haemorrhage, placental abruption and placenta praevia (104 000), and FGR (95 000). 1, 2, [19] [20] [21] Other conditions associated with stillbirth that were modelled were syphilis (95 000), malaria (38 000) and multiple pregnancy/abnormal presentation (19 000). The model estimated 946 000 stillbirths associated with all conditions, consistent with the approximately 935 000 third-trimester stillbirths in SSA reported in the Lancet Stillbirth Series. 2 No single condition caused more than 15% of all stillbirths.
We modelled the impact of a series of interventions for each of the above conditions. Tables 1-3 show the detailed summary of these analyses for each condition. Table 4 summarises the impact on stillbirth of the most successful combination of interventions for each of the eight conditions modelled. Table 1 first summarises the various scenarios related to stillbirths from prolonged/obstructed labour and uterine rupture. If these conditions were untreated, an estimated 218 500 stillbirths would occur in SSA (scenario 1). With interventions at their current usage, including moderate diagnosis of obstructed labour and penetration and utilisation of CS, an estimated 169 700 stillbirths are attributed to obstructed labour and ruptured uterus (scenario 2). Hence, current interventions may reduce the stillbirths in SSA associated with obstructed labour by about 48 800 (22%). The subsequent scenarios estimate stillbirths associated with obstructed labour and ruptured uterus with various interventions. As the stillbirth rate rises with continuing delay in delivery, 22 these scenarios consider whether the intervention was performed for a diagnosis of prolonged labour only, or if the intervention was delayed and the condition progressed to obstructed labour, or further to prolonged obstructed labour. Introducing a partograph to better diagnose prolonged labour (scenario 3) is estimated to reduce stillbirths by about 54 600. Improved diagnosis of prolonged labour-before development of obstructed labour-and transferring to hospitals with current levels of care (scenario 4), would reduce stillbirths by 116 700. Improving the availability of operative vaginal delivery, including forceps and vacuum extraction in the second stage of labour (scenario 5), reduces stillbirths by 37 100. If improved diagnosis, transfer and timely CS were combined (scenario 6), stillbirths in SSA would be reduced by 139 400. Hospital care for all women with current levels of interventions would reduce stillbirths by about 107 600, while provision of all interventions including early diagnosis of prolonged labour, hospitalisation and access to early CS to all women, would prevent 149 500 stillbirthsassociated with this condition in SSA, a reduction of 88.1% (scenario 8). Table 1 also presents stillbirths associated with fetal distress, not considered in the other analyses, including de novo fetal distress and cord accidents. We estimate the stillbirths associated with fetal distress and cord accidents without any treatment and then with current treatments as follows: de novo fetal distress, 114 300 and 111 400 and cord accidents, 38 800 and 37 800. Therefore when cord accidents and de novo fetal distress are combined (scenario 2) a total of 153 000 stillbirths occurred with no treatment (scenario 1) and 149 200 with current levels of treatment. Hence. few improvement in stillbirths associated with these conditions have occurred with current care, most likely because of limited diagnosis of fetal distress, and little ability to address these conditions once diagnosed. 22 For these conditions, potential interventions include better fetal distress monitoring, transfer to a hospital, improved access to CS and hospital delivery. In scenarios 3 through 5, individual interventions have relatively small impacts on stillbirths, but in combination, (scenario 6) stillbirths are reduced by nearly 55 200. Scenario 7 suggests that transferring women to the hospital for delivery, without improving other interventions, reduces stillbirths by only 11 800. However, combining all the other interventions with hospital delivery may prevent more than 120 700 stillbirths from fetal distress and cord accidents in SSA, a reduction of 80.9% (scenario 8).
Evaluation of stillbirths associated with pre-eclampsia/ eclampsia is also shown in Table 1 . In contrast to maternal mortality where most hypertensive maternal deaths are associated with eclampsia, most stillbirths caused by hypertensive disease occur secondary to pre-eclampsia. 23 Without any interventions, MANDATE estimates 129 100 stillbirths would be associated with pre-eclampsia/eclampsia (scenario 1). With current interventions, 118 500 stillbirths are associated with pre-eclampsia/eclampsia in SSA (scenario 2). Scenario 3 estimates that improved diagnosis of preeclampsia, by measuring blood pressure and proteinuria, with all other interventions held constant, would reduce stillbirths by 19 000. Addition of appropriate hospital transfer for those diagnosed results in 33 700 fewer stillbirths compared with current treatment (scenario 4). If all births were in a hospital with current care, stillbirths would be reduced by only 22 000 (scenario 7). However, if all births occurred in a hospital with improved diagnostics for PE, monitoring the mother and fetus for deteriorating status, and early CS (scenario 8), 81 300 stillbirths (68.6% of the current total) would be averted in SSA. Table 2 shows the MANDATE analyses of antepartum/ intrapartum haemorrhage (placenta praevia plus abruption). With no interventions, an estimated 106 900 stillbirths would result from antepartum/intrapartum haemorrhage instead of the 106 000 (scenario 1 and 2) observed with current care. Hence, current care in SSA probably prevents few stillbirths associated with antepartum/intrapartum haemorrhage. Improved early diagnosis of antepartum/intrapartum haemorrhage only prevents 4400 stillbirths and when appropriate transfer is added, a total of 9300 stillbirths may be prevented. Providing late CS, which may save the mother's life, prevents about 200 stillbirths while improving access to early or timely CS prevents about 3300 stillbirths (scenarios 5). Hence, adding high rates of improved diagnosis, transfer and CS separately all cause modest reductions of stillbirths. Moving all deliveries to a hospital with the current levels of care also prevents only a modest number (200) of stillbirths (data not shown). However, with these interventions combined, so that women receive improved diagnosis, early access to CS and hospital delivery, only 46 300 stillbirths would occur related to antepartum haemorrhage, thereby preventing 59 600 stillbirths (56.3%) compared with current treatment (scenario 8).
With no interventions, 95 100 stillbirths would be associated with FGR in SSA ( Table 2) . Current interventions result in minimal stillbirth reductions from this condition, preventing only 2500 stillbirths (scenario 1 and 2). Improved diagnosis of FGR with third-trimester ultrasound for hospital deliveries prevents only 40 additional stillbirths (data not shown). If this diagnostic test were available at all sites of care, without any other changes, only 80 stillbirths would be prevented compared with current care (scenario 3). If appropriate transfer to a hospital occurred for those diagnosed with FGR (scenario 4), only 650 Table 3 . With no interventions, an estimated 106 000 stillbirths would be associated with maternal syphilis; currently there are 88 800 (scenario 1 and 2). With improved screening alone (scenario 3), 20 700 stillbirths could be prevented over current care, and with improved antibiotic availability without increased screening, 14 700 stillbirths would be prevented (scenario 4). Improved screening and antibiotics together would reduce stillbirths by 71.3% or 55 000 (scenario 5).
The MANDATE model also estimates stillbirths associated with malaria in SSA (Table 3) . With no interventions, 62 600 malaria-associated stillbirths occur, whereas with current interventions there are 37 400, (scenarios 1 and 2), a reduction mostly attributable to prevention of maternal malaria with bednets, intermittent preventive treatment (IPT), and treatment of maternal malaria. 24 With improved access to bednets, an additional 4100 stillbirths could be prevented and with greater IPT, a reduction of 6600 additional stillbirths (scenarios 3 and 4). Better access to both bednets and IPT, prevents 10 000 stillbirths (scenario 5). With improved maternal malaria diagnosis, transfer of mothers to appropriate care, and treatment of the maternal malaria, a reduction of 11 800 stillbirths could occur (scenario 7). With better prophylaxis with bednets and IPT as well as diagnosis and treatment for maternal malaria, 17 500 stillbirths would be prevented in SSA, a reduction of 46.7% from current estimates. Table 3 also summarises stillbirths from multiple births and abnormal presentations. We estimate the stillbirths associated with each condition without any treatment, and with current treatments as follows: breech 9700 and 9400, and multiple births 9500 and 9200, respectively. Together, with no treatment, we expect 19 200 stillbirths and with current care 18 700 stillbirths (scenarios 1 and 2). Hence, current care provides little improvement in stillbirth rates associated with these conditions, mostly because of limited diagnosis of these conditions before labour, and little ability to address these conditions once diagnosed. 25, 26 For each condition, the interventions include monitoring for fetal distress, transfer to a hospital, improved access to CS and hospital delivery. As with fetal distress, the individual interventions (scenarios 3 through 5) have only a small impact on stillbirths. Combining the interventions (scenario 6) reduces stillbirths associated with breech and multiples by about 6900. Hospital delivery alone with current levels of the other interventions has a small impact on stillbirths (scenario 7), but when the other interventions are combined with hospital care, stillbirths in SSA associated with breech presentation and multiple pregnancy are reduced by 16 900, or about 90% (scenario 8). Table 4 compares the estimated maximum reduction in stillbirths for the various conditions modelled. The largest reduction in stillbirths will come from interventions aimed at several conditions, obstructed labour and uterine rupture, fetal distress and cord prolapse, pre-eclampsia/ eclampsia, FGR and antepartum haemorrhage including placental abruption and praevia. For each condition, the pathway to reduce stillbirths requires condition recognition or diagnosis, fetal monitoring for risk, and timely delivery, often by CS/labour induction in a hospital. In SSA, syphilis and malaria are still responsible for large numbers of stillbirths and are the only conditions modelled for which significant stillbirth reductions are likely to occur with outpatient screening and treatment alone.
Discussion

Main findings
This analysis estimates third-trimester stillbirths in SSA, including the number that would have occurred without any interventions, and the stillbirths that could be averted with various interventions. A number of observations are apparent from this analysis. Several obstetric and fetal conditions cause stillbirths; and no condition is responsible for more than 15% of stillbirths. The model suggests that current care has resulted in a moderate decline in stillbirths in SSA for some conditions, whereas for others, little change in the stillbirth rate has occurred. Targeting one or even several conditions in SSA is unlikely to have a major impact on overall stillbirth rates.
Obstetric care in SSA differs considerably from that in HIC. There are far fewer general physicians and even fewer obstetricians, paediatricians and anaesthesiologists. 27 Fewer births occur in hospitals and for the most part, deliveries occur either at home or in poorly equipped clinics. 28 Nearly 40% of births are attended by a family member or by a traditional birth attendant. 13 These practitioners have little or no training, often cannot read, write or use numbers, and cannot take blood pressures. 29 Even when women are transported to the hospital for obstetric management, the quality of care is often poor. Many hospitals are not staffed by physicians, especially on nights and weekends, and many do not provide CS or blood transfusions. Neonatal resuscitation is irregularly available. 30 It is therefore not surprising that the stillbirth rates in SSA approximate those seen in HIC before the availability of modern obstetric care.
Third-trimester stillbirth rates in SSA generally range from 20 to 40 per 1000 births, rates ten-fold higher than the lowest rates (2-3 per 1000 births) in countries such as Norway and Japan. 1 Historically, rates in the USA and other HICs were similar to the current stillbirth rates in SSA. These rates began to fall in most HICs in the 1930s, and have gradually declined to their current levels. No single intervention appears responsible for this decline, but temporally, the reduction began with the introduction of prenatal care including screening for pre-eclampsia and hospital delivery, and the continued decline seems to be associated with increasing CS for prolonged and obstructed labour, monitoring for fetal distress, monitoring of fetal growth, and the increasing labour induction and CS rates for a variety of obstetric conditions including pre-eclampsia, post-dates, multiple gestations and abnormal presentations. 14, 31 Our modelling suggests that if pregnant women in SSA received a relatively limited number of interventions targeted at eight to ten obstetric conditions, the stillbirth rates would fall substantially and could approach rates in HIC today.
Strengths and limitations
This study has a number of strengths and weaknesses. Weaknesses include that estimates related to the prevalence of conditions causing stillbirths and the associated CFRs vary, and other estimates could be justified. 6 Further, estimates of current penetration and utilisation for interventions were often based on survey data collected once every 5-10 years. These estimates were rarely disaggregated by place such as hospital, clinic or home, rural or urban, and were rarely population based. It is also difficult to model complicated medical conditions and their treatments, and how closely our modelling results may approximate actual practice is unknown. Nevertheless, we made extensive efforts to collect and validate the most reliable data from multiple sources and believe that substantial information can be learned from the conditions modelled as they relate to stillbirths. Most important, these analyses allow comparison of the relative reductions in stillbirths for each condition associated with various combinations of interventions.
A pattern between the interventions and stillbirth reduction numbers becomes apparent in considering the conditions responsible for stillbirths. First, single interventions, even at high penetration and utilisation, for the most part, will have limited stillbirth reductions. This is especially apparent when we modelled individual treatments confined to hospitals. Since a relatively small proportion of women deliver in a hospital and average SSA hospitals provide limited care, it is not surprising that targeting hospitalised women with a single intervention, or even having more women deliver in hospitals with current care, averts few additional stillbirths. Second, the mother or her caregiver's identification of the conditions causing stillbirth is crucial to initiate treatment. Whether the intervention is for preeclampsia, placental abruption, obstructed labour, poor fetal growth or many other conditions, diagnosis of the condition is crucial for transfer to a higher level of care, appropriate monitoring, and the initiation of treatment. Third, a series of interventions is often necessary for the greatest impact. These might include diagnosing the maternal condition, transfer to a hospital, monitoring the fetus for risk of stillbirth and finally CS/labour induction. Eliminating any step results in far fewer stillbirths averted. And finally, CS and sometimes induction of labour are frequently the life-saving interventions necessary to avert a stillbirth. Without the ability to deliver the fetus in a timely manner, all the other interventions are often in vain.
Interpretation
This study is the first of which we are aware that evaluates potential stillbirth reductions in LIC according to each condition that causes the fetal death. Nevertheless, the results are broadly consistent with other modelling efforts of the interventions necessary to reduce stillbirths. In the Bhutta et al. 8 study, the intervention likely to have the biggest impact on stillbirths was delivery at a facility able to provide emergency obstetric care. For most conditions, along with diagnosis and transfer, hospital care including fetal monitoring and CS, resulted in the largest stillbirth reductions. Only for a few conditions such as syphilis and malaria was outpatient prevention or treatment associated with substantial reductions in stillbirth, and these conditions were responsible for a relatively small proportion of all stillbirths.
Conclusion
To substantially reduce stillbirths, a number of obstetric and fetal conditions must be considered, prevented or screened for, and when present, the mother will often require care in a facility that can monitor the fetal condition and hasten delivery, often by CS. If these interventions were available in SSA, the majority of stillbirths would be averted, as would a substantial number of maternal and neonatal deaths. This approach will neither be easy nor inexpensive, but it is possible to achieve and the right thing to do. Every country in SSA, and other LICs worldwide, will need such an approach to attain the Every Newborn Action Plan target of fewer than 12 stillbirths per 1000 births by 2030. 32 
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